Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML

Bob Löwenberg, T Pabst, J Maertens, Yvette van Norden, BJ Biemond, HC Schouten, O Spertini, E Vellenga, C Graux, V Havelange, Georgine Greef, O de Weerdt, M Legdeur, J Kuball, MVM Kooy, BT Gjertsen, Mojca Jongen - Lavrencic, AAV de Loosdrecht, D van Lammeren-Venema, B HodossyDA Breems, Y Chalandon, J Passweg, Peter Valk, MG Manz, GJ Ossenkoppele

Research output: Contribution to journalArticleAcademicpeer-review

88 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1636-1645
Number of pages10
JournalBlood
Volume129
Issue number12
DOIs
Publication statusPublished - 2017

Research programs

  • EMC MM-02-41-03

Cite this